Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients

Razan El Ramahi, Alison Freifeld

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Influenza infection causes increased morbidity and higher mortality in patients receiving treatment of underlying cancer, particularly in those with hematological malignancy or patients who have undergone hematopoietic stem-cell transplantation. The illness is characterized by seasonality and nonspecific clinical manifestations of upper respiratory infection at a time when other respiratory illnesses are common in the community, making the diagnosis challenging. However, accurate and timely diagnosis by new molecular techniques is crucial in the management of immunocompromised patients, because delays in initiating appropriate therapy can have devastating consequences. Emergence of viral resistance to currently used antiviral agents is of concern, particularly in immunocompromised hosts, and warrants continued monitoring and surveillance. Early and effective treatment improves outcomes, but optimal therapeutic strategies in patients with cancer are not well defined. Health care and research efforts should focus on defining treatment guidelines in patients with cancer and attempt to improve on current vaccination strategies.

Original languageEnglish (US)
Pages (from-to)177-184
Number of pages8
JournalJournal of oncology practice
Volume15
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

Human Influenza
Epidemiology
Immunocompromised Host
Infection
Neoplasms
Health Services Research
Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
Therapeutics
Respiratory Tract Infections
Antiviral Agents
Vaccination
Guidelines
Morbidity
Mortality

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients. / El Ramahi, Razan; Freifeld, Alison.

In: Journal of oncology practice, Vol. 15, No. 7, 01.07.2019, p. 177-184.

Research output: Contribution to journalArticle

@article{344d4fceab5f45deb3c96021eab693e2,
title = "Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients",
abstract = "Influenza infection causes increased morbidity and higher mortality in patients receiving treatment of underlying cancer, particularly in those with hematological malignancy or patients who have undergone hematopoietic stem-cell transplantation. The illness is characterized by seasonality and nonspecific clinical manifestations of upper respiratory infection at a time when other respiratory illnesses are common in the community, making the diagnosis challenging. However, accurate and timely diagnosis by new molecular techniques is crucial in the management of immunocompromised patients, because delays in initiating appropriate therapy can have devastating consequences. Emergence of viral resistance to currently used antiviral agents is of concern, particularly in immunocompromised hosts, and warrants continued monitoring and surveillance. Early and effective treatment improves outcomes, but optimal therapeutic strategies in patients with cancer are not well defined. Health care and research efforts should focus on defining treatment guidelines in patients with cancer and attempt to improve on current vaccination strategies.",
author = "{El Ramahi}, Razan and Alison Freifeld",
year = "2019",
month = "7",
day = "1",
doi = "10.1200/JOP.19.00350",
language = "English (US)",
volume = "15",
pages = "177--184",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "7",

}

TY - JOUR

T1 - Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients

AU - El Ramahi, Razan

AU - Freifeld, Alison

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Influenza infection causes increased morbidity and higher mortality in patients receiving treatment of underlying cancer, particularly in those with hematological malignancy or patients who have undergone hematopoietic stem-cell transplantation. The illness is characterized by seasonality and nonspecific clinical manifestations of upper respiratory infection at a time when other respiratory illnesses are common in the community, making the diagnosis challenging. However, accurate and timely diagnosis by new molecular techniques is crucial in the management of immunocompromised patients, because delays in initiating appropriate therapy can have devastating consequences. Emergence of viral resistance to currently used antiviral agents is of concern, particularly in immunocompromised hosts, and warrants continued monitoring and surveillance. Early and effective treatment improves outcomes, but optimal therapeutic strategies in patients with cancer are not well defined. Health care and research efforts should focus on defining treatment guidelines in patients with cancer and attempt to improve on current vaccination strategies.

AB - Influenza infection causes increased morbidity and higher mortality in patients receiving treatment of underlying cancer, particularly in those with hematological malignancy or patients who have undergone hematopoietic stem-cell transplantation. The illness is characterized by seasonality and nonspecific clinical manifestations of upper respiratory infection at a time when other respiratory illnesses are common in the community, making the diagnosis challenging. However, accurate and timely diagnosis by new molecular techniques is crucial in the management of immunocompromised patients, because delays in initiating appropriate therapy can have devastating consequences. Emergence of viral resistance to currently used antiviral agents is of concern, particularly in immunocompromised hosts, and warrants continued monitoring and surveillance. Early and effective treatment improves outcomes, but optimal therapeutic strategies in patients with cancer are not well defined. Health care and research efforts should focus on defining treatment guidelines in patients with cancer and attempt to improve on current vaccination strategies.

UR - http://www.scopus.com/inward/record.url?scp=85064721368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064721368&partnerID=8YFLogxK

U2 - 10.1200/JOP.19.00350

DO - 10.1200/JOP.19.00350

M3 - Article

C2 - 30970229

AN - SCOPUS:85064721368

VL - 15

SP - 177

EP - 184

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 7

ER -